MiR-124 is also associated with many different diseases; however, in malignant diseases, it plays a role by inhibiting Caspase-3 and -9 activation, WNT/B-catenin pathway, PI3K/AKT and MAPK/ERK pathways, and was shown to be downregulated in a great variety of cancers [80]. Here, AKT1 is linked to cancer.